Tumorcode, a software to simulate vascularized tumors

EPJE highlight: Tumorcode, a software to simulate vascularized tumors
Rendering of a bulk tissue tumor simulation. Credit: Springer

The tumor vasculature is a major target of anticancer therapies. Rieger, Fredrich and Welter at Saarland University, Germany have been pursuing a quantitative analysis of the physical determinants of vascularized tumors for several years. With the help of computer simulations they have been able to recapitulate the knowledge accrued from in vitro research of tumor spheroids, animal models and clinical studies and have re-created a vascularized tumor system in silico.

They have recently released tumorcode, a software that assembles several known models into a multi-scale approach which allows to describe at length scales relevant for clinical applications. The code and a detailed user manual are open and publically available, in the hope that further use and refinements will accelerate progress and discovery in the field.

In this EPJE Tips and Tricks paper the authors present the technical aspects following the workflow of a typical simulation procedure. Importantly their approach allows the study of topological and functional aspects at the same time, which is relevant for therapeutic treatments.

The tumorcode source-code is available under at: https://github.com/thierry3000/tumorcode


Explore further

Promising target for treating brain tumors in children

More information: Heiko Rieger et al. Physics of the tumor vasculature: Theory and experiment, The European Physical Journal Plus (2016). DOI: 10.1140/epjp/i2016-16031-9

Thierry Fredrich et al. Tumorcode, The European Physical Journal E (2018). DOI: 10.1140/epje/i2018-11659-x

Journal information: European Physical Journal E

Provided by Springer
Citation: Tumorcode, a software to simulate vascularized tumors (2018, May 2) retrieved 18 January 2020 from https://phys.org/news/2018-05-tumorcode-software-simulate-vascularized-tumors.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments